Our differentiating capabilities to design best-in-class therapeutics rest on five cornerstones:
Machine Learning Models
Integrated Team, Rapid Iterations
We have built an end-to-end platform for heterobifunctional degrader discovery which we are expanding to other chemically-induced proximity applications.
We develop Covalent Therapeutics using our proprietary suite of proteome-wide datasets, assays, and covalent library.